ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) shares rose 0.8% on Friday. The company traded as high as $1.35 and last traded at $1.32. 137,500 shares traded hands during trading, an increase of 576% from the average session volume of 20,327 shares. The stock had previously closed at $1.31.
ImmunoPrecise Antibodies Trading Down 3.3%
The company has a 50-day moving average price of $1.36 and a 200-day moving average price of $1.40.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Holdings Inc is a biotechnology company that provides antibody discovery and development services to pharmaceutical, biotechnology and academic research organizations. Through its operations in Canada and other jurisdictions, the company supports projects ranging from early-stage target research and antibody generation to optimization and preclinical development.
The company develops monoclonal and polyclonal antibodies, recombinant proteins and related research reagents.
Recommended Stories
- Five stocks we like better than ImmunoPrecise Antibodies
- Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline
- Why Western Digital’s AI Storage Boom Defies the Chip Sell-Off
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
